0001662382 true 0001662382 2021-10-07 2021-10-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

(Amendment No. 1)

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): October 7, 2021

 

Brain Scientific Inc.

 

(Exact name of registrant as specified in its charter)

 

Nevada   333-209325   81-0876714

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

125 Wilbur Place, Suite 170

Bohemia, NY 11716

(Address of Principal Executive Offices)

 

(917) 388-1578

(Registrant’s telephone number, including area code)

 

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Explanatory Note

 

This Amendment No. 1 on Form 8-K/A is being filed by Brain Scientific Inc. (the “Company,” “we,” “us,” or “our”), to amend the Current Report on Form 8-K we filed on October 7, 2021 (the “Original Report”) to provide the disclosures required by Item 9.01 of Form 8-K that were previously omitted from the Original Report as permitted by Item 9.01(a)(4) of Form 8-K. Except as provided herein, the disclosures made in the Original Report remain unchanged.

 

Item 2.01 Completion of Acquisition or Disposition of Assets.

 

On June 11, 2021, Brain Scientific Inc. (the “Company”) entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Piezo Motion Corp., a Delaware corporation (“Piezo”), and BRSF Acquisition Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub was to be merged with and into Piezo, whereby Merger Sub would cease to exist and Piezo would survive as a wholly owned subsidiary of the Company (the “Merger”). On October 1, 2021 the Company, Piezo and the Merger Sub entered into an Amendment to Merger Agreement (the “Merger Agreement Amendment”) to revise certain provisions within the Merger Agreement involving the post-Merger composition of Company management and certain post-Merger arrangements with the Company’s outgoing principal executive officer, Boris Goldstein. The Merger was completed on October 1, 2021.

 

We filed the Original Report describing the transactions contemplated by the Merger Agreement on October 7, 2021, and we are now filing this amendment to include the historical financial statements and pro forma financial information required by Item 9.01 of Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.

 

(a) Financial Statements of Business Acquired. The audited consolidated financial statements of Piezo Motion Corp. as of and for the years ended December 31, 2020 and December 31, 2019, and the accompanying notes to the audited financial statements, are attached hereto as Exhibit 99.1 and are incorporated herein by reference thereto. The unaudited financial statements of Piezo Motion Corp. for the nine months ended September 30, 2021 and June 30, 2020, and the accompanying notes to the unaudited financial statements, are attached hereto as Exhibit 99.2 and are incorporated herein by reference thereto.

 

(b) Pro-forma Financial Information. The following information is attached hereto as Exhibit 99.3 and incorporated herein by reference thereto:

 

(i) Unaudited Pro Forma Condensed Combined Financial Information of Brain Scientific Inc. and Piezo Motion Corp as of and for the year ended December 31, 2020 and for the nine months ended September 30, 2021.

 

(ii) Notes to the Unaudited Pro Forma Condensed Combined Financial Information.

 

(c) Exhibits.

 

Exhibit No.   Description
     
99.1   Audited Financial Information of Piezo Motion Corp as of and for the years ended December 31, 2020 and December 31, 2019.
     
99.2   Unaudited Financial Information of Piezo Motion for the nine months ended September 30, 2021 and 2020.
     
99.3   Unaudited Pro Forma Condensed Combined Financial Information of Brain Scientific Inc. and Piezo Motion Corp. as of and for the year ended December 31, 2020 and for the nine months ended September 30, 2021.
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Brain Scientific Inc.
     
Dated: December 15, 2021 By: /s/ Hassan Kotob  
  Name:  Hassan Kotob
  Title: Chief Executive Officer

 

 

2

 

Exhibit 99.1

 

 

 

 

 

 

 

 

 

 

DTI Motion Corp.

 

AUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

FOR THE YEARS ENDED
DECEMBER 31, 2020 AND 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Financial Statements

 

DTI Motion Corp. and Subsidiary

 

  Page
Report of Independent Registered Public Accounting Firm 2
   
Consolidated Balance Sheets as of December 31, 2020 and 2019 3
   
Consolidated Statements of Operations for the years ended December 31, 2020 and 2019 4
   
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the years ended December 31, 2020 and 2019 5
   
Consolidated Statements of Cash Flows for the years ended December 31, 2020 and 2019 6
   
Notes to the consolidated financial statements 7

 

1

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Shareholders of
DTI Motion Corporation

 

Opinion on the Financial Statements

 

We have audited the accompanying balance sheets of DTI Motion Corporation (the Company) as of December 31, 2020 and 2019, and the related statements of operations, changes in shareholders’ equity, and cash flows for the years then ended, and the related notes and schedules (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flow for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

Substantial Doubt About the Company’s Ability to Continue as a Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 10, the Company has incurred net losses and negative cash flow from operations since inception. These factors, and the need for additional financing in order for the Company to meet its business plans raises substantial doubt about the Company’s ability to continue as a going concern. Our opinion is not modified with respect to that matter.

 

 
We have served as the Company’s auditor since 2018.  
   
Tampa, Florida  
March 5, 2021  

 

 

 

3001 N. Rocky Point Dr. East, Suite 200 i Tampa, Florida 33607 i 813.367.3527

 

 

 

2

 

 

DTI Motion Corp. and Subsidiary

Consolidated Balance Sheets

 

    As of
December  31,
2020
    As of
December  31,
2019
 
Assets            
Current assets            
Cash and cash equivalents   $ 68,943     $ 169,501  
Inventory     44,904       -  
Advances to officers     7,542       1,983  
Deposits and prepaid expenses     12,000       21,950  
Total current assets     133,389       193,434  
                 
Fixed assets                
Property, plant and equipment, net     91,742       77,300  
Total Assets   $ 225,131     $ 270,734  
                 
Liabilities & Stockholders’ Equity                
Current liabilities                
Accounts payable and accrued liabilities   $ 1,444,476     $ 236,698  
Accrued interest     26,766       -  
Notes payable     650,000       -  
Total current liabilities     2,121,242       236,698  
                 
Long-term liabilities                
Paycheck protection program (PPP) loan     111,477       -  
Total long-term liabilities     111,477       -  
Total Liabilities     2,232,719       236,698  
                 
Commitments and contingencies                
                 
Stockholders’ Equity                
Series A Preferred stock, $0.0001 par value; 0 and 2,766,317 shares issued and outstanding at December 31, 2020 and 2019, respectively     -       277  
                 
Series B Preferred stock, $0.0001 par value; 0 and 2,424,625 shares issued and outstanding at December 31, 2020 and 2019, respectively     -       242  
                 
Series C Preferred stock, $0.0001 par value; 0 and 5,070,157 shares issued and outstanding at December 31, 2020 and 2019, respectively     -       507  
                 
Common stock, $0.0001 par value; 60,000,000 shares authorized; 10,058,259 and 7,678,535 shares issued and outstanding at December 31, 2020 and 2019, respectively     1,006       768  
Additional paid in capital     11,169,643       10,407,450  
Accumulated deficit     (13,178,237 )     (10,375,208 )
Total Stockholders’ Equity     (2,007,588 )     34,036  
Total Liabilities and Stockholders’ Equity   $ 225,131     $ 270,734  

 

See accompanying notes to the financial statements.

 

3

 

 

DTI Motion Corp. and Subsidiary

Consolidated Statements of Operations

 

    For the years ended  
    December 31,  
    2020     2019  
Revenue   $ 93,664     $ 8,558  
                 
Cost of sales     43,762       10,827  
                 
Gross profit     49,902       (2,269 )
                 
General and administrative corporate expenses:                
Personnel expenses     1,027,259       562,383  
General and administrative expenses     1,208,538       528,357  
Stock-based compensation     355,534       518,663  
Research and development     210,706       226,846  
Depreciation expense     17,353       16,860  
Total general and administrative corporate expenses     2,819,390       1,853,109  
                 
Loss from operations     (2,769,488 )     (1,855,378 )
                 
Other income (expense):                
Other income     -       1,231  
Loss on disposal of assets     (4,067 )     -  
Interest expense     (29,474 )     (3,486 )
Total other income (expense)     (33,541 )     (2,255 )
                 
Net loss   $ (2,803,029 )   $ (1,857,633 )
                 
Basic and diluted earnings per share on net loss   $ (0.31 )   $ (0.24 )
                 
Weighted average shares outstanding - basic and diluted     9,018,629       7,678,535  

 

See accompanying notes to the financial statements.

 

4

 

 

DTI Motion Corp. and Subsidiary

Consolidated Statement of Changes in Stockholders’ Equity (Deficit)

For the Years Ended December 31, 2020 and 2019

 

    Series A
Preferred Stock
    Series B
Preferred Stock
    Series C
Preferred Stock
    Common Stock     Additional
Paid in
    Accumulated        
    Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Capital     Deficit     Total  
Balance December 31, 2018     2,766,317     $       277       2,424,265     $ 242       3,742,903     $ 374       7,678,535     $ 768     $ 8,448,927     $ (8,517,575 )   $ (66,987 )
                                                                                         
Sale of Series C Preferred Stock     -       -       -       -       1,327,254       133       -       -       648,395       -       648,528  
                                                                                         
Stock-option based compensation     -       -       -       -       -       -       -       -       518,663       -       518,663  
                                                                                         
Warrants issued in connection with the sale of Series C Preferred Stock     -       -       -       -       -       -       -       -       791,465       -       791,465  
                                                                                         
 Net Loss     -       -       -       -       -       -       -       -               (1,857,633 )     (1,857,633 )
                                                                                         
Balance December 31, 2019     2,766,317       277       2,424,265       242       5,070,157       507       7,678,535       768       10,407,450       (10,375,208 )     34,036  
                                                                                         
Sale of Series C Preferred Stock     -       -       -       -       80,000       8       -       -       53,456       -       53,464  
                                                                                         
Warrants issued in connection with the sale of Series C Preferred Stock     -       -       -       -       -       -       -       -       46,536       -       46,536  
                                                                                         
Issuance of common stock for director services     -       -       -       -       -       -       210,000       21       34,084       -       34,105  
                                                                                         
Recapitalization at reverse merger - May 20, 2020     (2,766,317 )     (277 )     (2,424,265 )     (242 )     (5,150,157 )     (515 )     2,111,465       211       618,673       -       617,850  
                                                                                         
Issuance of common stock for services     -       -       -       -       -       -       58,259       6       9,444       -       9,450  
Net loss     -       -       -       -       -       -       -       -               (2,803,029 )     (2,803,029 )
                                                                                         
Balance December 31, 2020     -     $ -       -     $ -       -     $ -       10,058,259     $ 1,006     $ 11,169,643     $ (13,178,237 )   $ (2,007,588 )

 

See accompanying notes to the financial statements.

 

5

 

 

DTI Motion Corp. and Subsidiary

Consolidated Balance Sheets

 

    For the years ended  
    December 31,  
    2020     2019  
             
Cash Flows from Operating Activities            
Net Loss   $ (2,803,029 )   $ (1,857,633 )
                 
Adjustments to reconcile net loss to net cash used by operating activities:                
Stock compensation     355,534       518,663  
Depreciation     17,353       16,860  
Loss on disposal of assets     4,067       -  
Changes in operating assets & liabilities                
Accounts receivable     -       112,000  
Inventory     (44,904 )     -  
Officer advances     (5,559 )     (1,983 )
Deposits & prepaid expenses     9,950       (12,863 )
Accounts payable and accrued liabilities     1,508,158       (69,457 )
Accrued interest     26,766       -  
Net cash used by operating activities     (931,664 )     (1,294,413 )
                 
Cash Flows from Investing Activities                
Capital expenditures     (30,371 )     (10,269 )
Net cash used by investing activities     (30,371 )     (10,269 )
                 
Cash Flows from Financing Activities                
Proceeds from notes payable     650,000       -  
Proceeds from PPP loan     111,477       -  
Proceeds from issuance of Series C Preferred Stock     100,000       -  
Issuance of preferred stock     -       1,439,993  
Net cash provided by financing activities     861,477       1,439,993  
                 
Increase in Cash     (100,558 )     135,311  
                 
Cash at beginning of period     169,501       34,190  
                 
Cash (and equivalents) at end of period   $ 68,943     $ 169,501  
                 
Supplemental Cash Flow Information                
Cash paid for interest   $ -     $ -  
Cash paid for income taxes   $ -     $ -  

 

See accompanying notes to the financial statements.

 

6

 

 

DTI MOTION, INC AND SUBSIDIARY

NOTES TO THE FINANCIAL STATEMENTS

DECEMBER 31, 2020

 

NOTE 1 - ORGANIZATION AND NATURE OF BUSINESS

 

DTI Motion Corp (“Motion or “the Company”) was formed as a Delaware corporation on January 24, 2020. The initial shareholding was set up on March 15, 2020 and a share offering was made at the end of March, 2020. On March 27, 2020, Motion entered into a secured, short-term loan in an amount up to $249,000 to Discovery Technology International, Inc. (“DTI”) for the purpose of funding of operations. The loan maturity was April 27, 2020. DTI was unable to repay the loan and the shareholders authorized a merger between Motion (legal acquirer) and DTI (accounting acquirer) which was completed on May 20, 2020. See Note 3 for further details on the share exchange.

 

DTI was converted from a limited liability partnership to a corporation on January 26, 2011 in the state of Florida. DTI’s office is located in Sarasota, Florida. DTI is a company focused on the ultrasonic standing wave-type piezo motor technology for rotary and linear motion. DTI has experience in the research and development, as well as the manufacturing, of piezo motors for high-tech industries across the globe.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The significant accounting policies of the Company are as follows:

 

Basis of Presentation and Consolidation

 

The Company has one wholly-owned subsidiary: Discovery Technology International, Inc. (“DTI”). The consolidated financial statements, which include the accounts of the Company and its wholly-owned subsidiary, are prepared in conformity with generally accepted accounting principles in the United States of America (U.S. GAAP). All significant intercompany balances and transactions have been eliminated. The consolidated financial statements, which include the accounts of the Company and its wholly-owned subsidiary, and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Financial Statements have been prepared using the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and presented in US dollars. The year end is December 31.

 

Use of Estimates

 

Management uses estimates and assumptions in preparing financial statements. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could differ from these estimates and assumptions.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains deposits primarily in one financial institution, which may at times exceed amounts covered by insurance provided by the U.S. Federal Deposit Insurance Corporation (“FDIC”). The Company has not experienced any losses related to amounts in excess of FDIC limits.

 

Fair Value of Financial Instruments

 

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

 

7

 

 

The following are the hierarchical levels of inputs to measure fair value:

 

Level 1 – Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

 

Level 2 – Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

Level 3 – Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and interest, certain notes payable, approximate their fair values because of the short maturity of these instruments. The Company accounts for its equity instruments (such as warrants and stock-based compensation) at fair value.

 

Property, Plant and Equipment

 

Property, plant and equipment are carried at cost. Depreciation is provided on the straight-line method over the assets estimated service lives. Expenditures for maintenance and repairs are charged to expense in the period in which they are incurred, and betterments are capitalized. The cost of assets sold or abandoned and the related accumulated depreciation are eliminated from the accounts and any gains or losses are reflected in the accompanying statements of operations of the respective period. The estimated useful lives range from 3 to 7 years.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, “Revenue from contracts with customers,” (Topic 606). Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company’s main revenue stream is from product sales. The performance obligation associated with a typical product sale will be satisfied upon shipment to the customer, and the revenue will be recognized at that time.

 

The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, the Company’s performance obligations are transferred to customers at a point in time, typically upon delivery.

 

8

 

 

Income Taxes

 

The Company follows Section 740-10-30 of the FASB ASC, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the fiscal year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the fiscal years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date. Through December 31, 2020, the Company has an accumulated deficit. Due to uncertainty of realization for these losses, a full valuation allowance is expected. Accordingly, no provision has been made for federal income taxes in the accompanying financial statements.

 

Stock based compensation

 

The Company records stock-based compensation in accordance with the provisions of FASB ASC Topic 718, “Accounting for Stock Compensation,” which establishes accounting standards for transactions in which an entity exchanges its equity instruments for goods or services. In accordance with guidance provided under ASC Topic 718, the Company recognizes an expense for the fair value of its stock awards at the time of grant and the fair value of its outstanding stock options as they vest, whether held by employees or others. As of December 31, 2020 and 2019 there were 0 and 1,101,762 options outstanding, respectively. For the years ended December 31, 2020 and 2019, the Company recorded $355,534 and $518,663 in stock-based compensation expenses, respectively which is included within general and administrative expenses on the accompanying statements of operations.

 

Recently Adopted Accounting Pronouncements

 

On June 20, 2018, the Financial Accounting Standards Board, or FASB issued ASU 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 is intended to reduce cost and complexity and to improve financial reporting for share-based payments to nonemployees (for example, service providers, external legal counsel, suppliers, etc.). Under the new standard, companies will no longer be required to value non-employee awards differently from employee awards. Meaning that companies will value all equity classified awards at their grant-date under ASC 718 and forgo revaluing the award after this date. The Company adopted ASU 2018-07 on January 1, 2019. The adoption of this standard did not have a material impact on the financial statements.

 

Financial Accounting Standards Board, or FASB, Accounting Standards Update, or ASU 2016-02 “Leases (Topic 842)”- In February 2016, the FASB issued ASU 2016-02, which will require lessees to recognize almost all leases on their balance sheet as a right-of-use asset and a lease liability. For income statement purposes, the FASB retained a dual model, requiring leases to be classified as either operating or finance. Classification will be based on criteria that are largely similar to those applied in current lease accounting, but without explicit bright lines. Lessor accounting is similar to the current model, but updated to align with certain changes to the lessee model and the new revenue recognition standard. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company has adopted this guidance effective January 1, 2019. The Company currently has an occupancy lease with a one-year term and has elected to apply the short term lease exception.

 

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

9

 

 

NOTE 3 – EXCHANGE AGREEMENT

 

On April 8, 2020, DTI Motion Corp (“DTIM”) along with Discovery Technology International, Inc., a Delaware corporation (“DTI”) and DTIM, Inc., a newly formed, wholly-owned subsidiary of DTIM (the “Merger- Sub”) entered into a merger agreement. The merger was considered effective on May 20, 2020. As part of the agreement the Merger-Sub merged with and into DTI with DTI surviving as a wholly-owned subsidiary of DTIM and all outstanding shares of the Company’s common stock (“DTI Common Stock”), Series A Preferred Stock (“DTI Series A Preferred Stock”), Series B Preferred Stock (“DTI Series B Preferred Stock”) and Series C Preferred Stock (“DTI Series C Preferred Stock”) and together with the DTI Company Common Stock, collectively, the “DTI Capital Stock”), automatically converted into shares of common stock of DTIM (“DTIM Common Stock”). In addition, all outstanding DTI stock options (“DTI Stock Options”) granted under DTI’s equity incentive plan (the “DTI EIP”) and common stock purchase warrants (“DTI Warrants”) were cancelled. Holders of such cancelled DTI Warrants received shares of DTIM Common Stock, all in consideration for and settlement of each holder’s cancellation of its DTI Warrants.

 

The merger has been accounted for as a reverse merger transaction, with DTI as the accounting acquirer and DTIM as the accounting acquiree. The acquisition of a private operating company (“DTI”) by a nonoperating shell company (“DTIM”) is considered in substance, a capital transaction rather than a business combination (or asset acquisition). That is, the transaction is a reverse recapitalization, equivalent to the issuance of shares by the private operating company for the net monetary assets of the shell company accompanied by a recapitalization. There is no goodwill or other intangible assets recognized.

 

NOTE 4 – PROPERTY, PLANT AND EQUIPMENT

 

Property, plant and equipment consisted of the following at December 31, 2020 and 2019:

 

    December 31,     December 31,  
    2020     2019  
             
Computer equipment   $ 4,164     $ 7,062  
Machinery and equipment     121,433       92,630  
Computer software     -       6,995  
Leasehold improvements     5,000       -  
Less: Accumulated depreciation     (38,855 )     (29,387 )
Total, net   $ 91,742     $ 77,300  

 

Depreciation expense was $17,353 and $16,860 for the years ended December 31, 2020 and 2019, respectively.

 

NOTE 5 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses as of December 31, 2020 and 2019, consisted of the following:

 

    December 31,     December 31,  
    2020     2019  
Accounts payable   $ 398,155     $ 46,542  
Accrued payroll     997,410       147,131  
Credit card payable     42,361       37,891  
Accrued director fees     5,133       5,134  
Accrued - other     1,417       -  
Total   $ 1,444,476     $ 236,698  

 

10

 

 

NOTE 6 – NOTES PAYABLE

 

In July 2020, Motion made an offering of convertible notes not to exceed approximately $2,400,000. In October, the Board authorized increasing the potential investment to not exceed $5,000,000. Unless earlier terminated by the Company, the offering shall terminate on April 30, 2021. These notes are payable by August 21, 2021, interest accruing at 10% per annum. At the completion of a qualifying investment, Motion, at its sole discretion may convert the loans and any accrued interest to common stock with a 120% multiplier on the value of the common stock in the qualifying investment. As of December 31, 2020, the carrying amount of these notes was $650,000 with accrued interest of $26,766.

 

NOTE 7 – PAYCHECK PROTECTION PROGRAM LOAN

 

In May 2020, DTI received a Paycheck Protection Program (PPP) loan under the terms of the CARES Act in the amount of $106,477 and an Economic Industry Disaster Loan (“EIDL”) of $5,000. The interest rate on the PPP loan is 1% fixed with a term of 24 months. DTI may apply for loan forgiveness.

 

NOTE 8 - EQUITY

 

On May 20, 2020 a merger was completed between Motion and DTI. The merger was approved by over 66% of all classes of stock for both Motion and DTI. Terms for the merger were included in a confidential term sheet. All common stock, preferred stock Series A, B and C, and warrants of DTI were converted. All DTI options were cancelled as of the merger date. See Footnote 3. The conversion ratio for the different classes of stock were agreed to by the shareholders in the merger. The conversion ratios were as follows:

 

    Conversion
ratio
 
DTI Pre-merger stockholders (Common Stock)     16.13  
DTI Pre-merger stockholders (Series A)     5.76  
DTI Pre-merger stockholders (Series B)     5.38  
DTI Pre-merger stockholders Series B Exchange Warrants     16.13  
DTI Pre-merger stockholders (Series C)     3.75  
DTI Pre-merger stockholder Series C Exchange Warrants     8.06  
Placement Agent Warrants     1.61  

 

Common stock

 

After the merger and recapitalization on May 20, 2020, there were 10,000,000 shares issued and outstanding.

 

On June 10, 2020, 24,759 shares were issued for commission on the March 2020 investment in Motion. Inclusive of shares issued to preserve anti-dilution of 33,500, the total shares issued were 58,259. The shares were valued at $9,450.

 

As of December 31, 2020 and 2019, there were 10,058,259 and 7,678,535 shares issued and outstanding, respectively.

 

DTI Preferred stock

 

In 2019, there were 15,000,000 shares authorized as preferred stock, of which 2,766,317 are designated as Series A, 3,390,780 are designated as Series B and 5,742,903 designated as Series C. 3,100,000 shares have yet to be designated. At the merger all DTI preferred stock was converted to common stock of Motion.

 

11

 

 

Series C Preferred Stock

 

Between March 20, 2019 and December 9, 2019, DTI sold 1,327,254 shares of Series C Preferred Stock for $1,659,068. The Company received $1,439,993 in net proceeds after $219,075 in stock issuance costs. In connection with the sale, the holders received 1,327,254 Class A Warrants and 663,627 Class B Warrants. The amount of $1,659,068 was allocated among the instruments as follows: (i) $867,603 to Series C Preferred Stock, (ii) $561,559 to Class A Warrants, and (iii) $229,906 to Class B Warrants.

 

In connection with the Series C Preferred issuances, the Company issued 712,431 warrants to the Series B Preferred holders to make them whole. These warrants were valued at $349,078 and are recorded on the statement of operations under stock-based compensation. At the merger the Series C preferred stock and warrants were converted to common stock of Motion.

 

On February 20, 2020 DTI issued 80,000 shares of Series C Preferred Stock and 120,000 warrants for $100,000.

 

The Company has selected the Black-Scholes-Merton (“BSM”) valuation technique to fair value the warrants because it believes that this technique is reflective of all the inputs that market participants would likely consider in transactions involving warrants. Significant inputs and results arising from the BSM calculation are as follows:

 

    December 31,
2020
  December 31,
2019
Underlying price   $1.25   $1.25
Contractual strike price   $1.25 - $3.00   $1.25 - $3.00
Contractual term to maturity   5.00 Years   5.00 Years
Market volatility:        
Equivalent Volatility   83.36%   66.17% - 130.70%
Interest rate   1.37%   1.37% - 3.04%

 

At the merger, the Series C preferred stock and warrants were converted to common stock of Motion.

 

Equity Incentive Plan

 

On August 19, 2011, the Board of Directors adopted DTI’s “2011 Equity Incentive Plan” (the “Plan”) effective immediately. The maximum number of options issuable under the Plan is 1,000,000 shares or additional amounts if needed under shareholder approval. The exercise price of the options granted under the plan is determined by the Board at its sole discretion. Options are exercisable over periods not exceeding ten years and vesting and exercisability is determined by the board at grant. The plan involves restricted stock and stock options. Stock options can be incentive stock options and non-qualified options.

 

During the year ended December 31, 2019, DTI granted a total of 105,000 options with an exercise prices of $1.25. The grant date value of these options was $104,550. Of the $104,550 in grant date fair value, $30,882 was recorded as stock-based compensation for the year ended December 31, 2019. Of the 880,000 options granted in 2018, $487,781 was recorded as stock-based compensation for the year ended December 31, 2019. The aggregate compensation expense for the year ended December 31, 2019 was $518,663. As of the merger date of May 20, 2020, all options were cancelled. As a result of the cancellation, the unvested portion of $311,979 was accelerated and the expense was charged in full immediately.

 

12

 

 

The Company selected the Black-Scholes-Merton (“BSM”) valuation technique to calculate the grant date fair values for the stock options because it believes that this technique is reflective of all the inputs that market participants would likely consider in transactions involving warrants. The inputs include the strike price, underlying price, term to expiration, volatility, and risk-free interest rate.

 

No options were outstanding as of December 31, 2020. At December 31, 2019 options outstanding were:

 

 

          Weighted     Weighted
          Average     Average
    Number     Exercise     Remaining
    of Options     Price     Contractual Life
Options Outstanding – January 1, 2019     1,060,000     $ 1.33     8.8 years
Issued     105,000     $ 1.32     10 years
Exercised     -              
Expired                    
Forfeited     (63,238 )   $          1.91     6.9 years
Options Outstanding – December 31, 2019     1,101,762     $ 1.40     7.9 years
Issued     -              
Exercised     -              
Expired     -              
Forfeited     -              
Cancelled at merger date     (1,101,762 )            
Options Outstanding – December 31, 2020     -     $      

 

Warrants

 

No warrants were outstanding for the Company at year end. The following table represents warrant activity for DTI as of and for the years ended December 31, 2020 and 2019:

 

          Weighted     Weighted
          Average     Average
    Number     Exercise     Remaining
  of Warrants     Price     Contractual Life
Warrants Outstanding – January 1, 2019     7,839,804     $ 1.85     4.0 years
Issued     2,119,553     $ 2.00     5.0 years
Exercised     -              
Expired     -              
Warrants Outstanding – December 31, 2019     9,959,357     $ 1.88     3.30 years
Issued     -              
Exercised     -              
Expired     -              
Cancelled at merger date     (9,959,357 )            
Warrants Outstanding – December 31, 2020     -              

 

13

 

 

NOTE 9 – COMMITMENTS AND CONTINGENCIES

 

During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with FASB ASC 450-20-50, Contingencies. The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals. As of December 31, 2020, the Company is not aware of any contingent liabilities that should be reflected in the financial statements.

 

The Company entered into employment agreements with its President and Chief Executive Officer as of March 15, 2020. Under the terms of these agreements the Company will be liable for severance and other payments under certain conditions. The employment agreements are for a period of 36 months and may be terminated by the Chief Executive Officer or President upon three months written notice.

 

The Company entered into a facilities’ lease on January 1, 2020 for a premise located at 6968 Professional Parkway East, Sarasota, FL 34240. The lease period is for one year. Under Topic 842, a short-term lease is a lease that, at the commencement date, has a ‘lease term’ of 12 months or less and does not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise. Although short-term leases are in the scope of Topic 842, a simplified form of accounting is permitted. A lessee can elect, by class of underlying asset, not to apply the recognition requirements of Topic 842 and instead to recognize the lease payments as lease cost on a straight-line basis over the lease term. The Company has elected the short-term method to account for these leases. Total rent expense for the years ending December 31, 2020 and 2019 were $45,551 and $42,571, respectively, which are included in general and administrative expense within the accompanying statements of operations.

 

NOTE 10 – GOING CONCERN

 

The Company’s financial statements are prepared using the generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. At December 31, 2020 and December 31, 2019, the Company had $68,493 and $169,501 in cash and $1,987,853 and $43,264 in negative working capital, respectively. For the years ended December 31, 2020 and 2019, the Company had a net loss of 2,803,029 and $1,857,633, respectively. Continued losses may adversely affect the liquidity of the Company in the future. In view of the matters described in the preceding paragraph, recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheets is dependent upon continued operations of the Company, which in turn is dependent upon the Company’s ability to raise additional capital, obtain financing and to succeed in its future operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

NOTE 11 – INCOME TAXES

 

The Company adopted the provisions of uncertain tax positions as addressed in ASC 740-10-65-1. As a result of the implementation of ASC 740-10-65-1, the Company recognized no increase in the liability for unrecognized tax benefits. As of December 31, 2020 the Company had net operating loss carry forwards of approximately $13,178,237 that may be available to reduce future years’ taxable income in varying amounts through 2030. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards.

 

14

 

 

The valuation allowance at December 31, 2020 was approximately $13,178,237. The net change in valuation allowance during the year ended December 31, 2020 was $(2,803,029). In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized.

 

The components of the net deferred tax asset (liability) at December 31, 2020 and, 2019 and the statutory tax rate, the effective tax rate and the elected amount of the valuation allowance are indicated below:

 

    December 31,     December 31,  
    2020     2019  
Net operating loss carry-forward   $ 13,178,237     $ 10,375,208  
Valuation Allowance     (13,178,237 )     (10,375,208 )
Net Deferred Tax Asset (Liability)   $ -     $ -  

 

Income tax benefit resulting from applying statutory rates in jurisdictions in which we are taxed (Federal and State of Florida) differs from the income tax provision (benefit) in our financial statements. The following table reflects the reconciliation for the years ended December 31, 2020 and 2019:

 

    Year Ended December 31,  
    2020     2019  
Benefit at federal and statutory rate     (21 )%     (21 )%
Change in valuation allowance     21 %     21 %
Effective tax rate     0 %     0 %

 

NOTE 12 – SUBSEQUENT EVENTS

 

On January 19, 2021, the Company issued a 10% convertible note for $250,000. The note matures on August 21, 2021 and is convertible to Company common stock at a 120% multiplier of the conversion rate of a public or private placement of $1,000,000 or greater.

 

The Company changed its name from DTI Motion Corp. to Piezo Motion Corp. on February 1, 2021.

 

The Company entered into a lease agreement for office space located in Sarasota, Florida. The term of the lease is for a period of two years commencing on February 1, 2021 and ending on February 1, 2023. The rent is $6,530 per month for year 1, $6,726 per month for year 2 and $6,928 per month for year 3. The Company will account for the lease under ASC 842 whereby the operating lease right-of-use assets and liabilities are recognized at the present value of the future lease payments at the lease commencement date.

 

On January 19, 2021 and February 10, 2021 respectively, the Company issued 10% convertible notes for $250,000 each, for a total of $500,000. The notes mature on August 21, 2021 and are convertible to Company common stock at a 120% multiplier of the conversion rate of a public or private placement of $1,000,000 or greater.

 

 

15

 

Exhibit 99.2

 

 

 

 

 

 

 

 

 

 

Piezo Motion Corp. (f/n/a DTI Motion Corp.) and Subsidiary

 

INTERIM CONSOLIDATED FINANCIAL STATEMENTS

 

FOR THE NINE MONTHS ENDED

SEPTEMBER 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Financial Statements

 

Piezo Motion Corp. (f/n/a DTI Motion Corp.) and Subsidiary

 

    Page
Consolidated Balance Sheets as of September 30, 2021 (Unaudited) and December 31, 2020   2
     
Consolidated Statements of Operations (Unaudited) for the three and nine months ended September 30, 2021 and 2020   3
     
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the three and nine months ended September 30, 2021 (Unaudited)   4
     
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the three and nine months ended September 30, 2020 (Unaudited)   5
     
Consolidated Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2021 and 2020   6
     
Notes to the unaudited consolidated financial statements   7

 

1

 

 

Piezo Motion Corp. (f/n/a DTI Motion Corp.) and Subsidiary

Consolidated Balance Sheets

 

    As of
September 30,
2021
    As of
December 31,
2020
 
    (Unaudited)        
Assets            
Current assets            
Cash and cash equivalents   $ 105,958     $ 68,943  
Accounts receivables     2,529       -  
Due from related parties     43,423       -  
Inventory     107,143       44,904  
Advances to officers     6,482       7,542  
Deposits and prepaid expenses     45,511       12,000  
Notes receivable – related party     603,067       -  
Total current assets     914,113       133,389  
                 
Fixed assets                
Property, plant and equipment, net     110,345       91,742  
Right of use asset     179,370       -  
Total Assets   $ 1,203,828     $ 225,131  
                 
Liabilities & Stockholders’ Equity                
Current liabilities                
Accounts payable & accrued liabilities   $ 2,277,484     $ 1,444,476  
Accrued interest     208,480       26,766  
Note payable     4,119,982       650,000  
Lease liability     70,893       -  
Total current liabilities     6,676,839       2,121,242  
                 
Paycheck protection loan     -       111,477  
Lease liability, non-current     110,162       -  
Total Liabilities     6,787,001       2,232,719  
                 
Commitments and contingencies                
                 
Stockholders’ Deficit                
                 
Common stock, $0.0001 par value; 60,000,000 shares authorized; 10,058,259 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively     1,006       1,006  
Additional paid in capital     11,169,643       11,169,643  
Accumulated deficit     (16,753,822 )     (13,178,237 )
Total Stockholders’ Deficit     (5,583,173 )     (2,007,588 )
Total Liabilities and Stockholders’ Deficit   $ 1,203,828     $ 225,131  

 

See accompanying notes to the consolidated financial statements.

 

2

 

 

Piezo Motion Corp. (f/n/a DTI Motion Corp.) and Subsidiary

Unaudited Consolidated Statements of Operations

Unaudited

 

    For the three months ended     For the nine months ended  
    September 30,     September 30,  
    2021     2020     2021     2020  
                         
Revenue   $ 5,275     $ 39,928     $ 14,482     $ 89,972  
                                 
Cost of sales     4,143       14,505       7,840       42,241  
                                 
Gross profit     1,132       25,423       6,642       47,731  
                                 
General and administrative corporate expenses:                                
General and administrative expenses     621,147       243,494       1,403,884       763,002  
Personnel expenses     795,742       221,511       1,454,180       635,441  
Sales and marketing expenses     260,545       43,409       488,704       73,495  
Depreciation expense     7,898       4,338       19,736       13,014  
Research and development     48,282       63,491       145,487       157,836  
Total general and administrative corporate expenses     1,733,614       576,243       3,511,991       1,642,788  
                                 
Loss from operations     (1,732,482 )     (550,820 )     (3,505,349 )     (1,595,057 )
                                 
Other income (expense):                                
Gain on forgiveness of paycheck protection loan     -       -       112,338       -  
Interest expense     (68,357 )     (10,572 )     (182,574 )     (11,892 )
Total other income (expense)     (68,357 )     (10,572 )     (70,236 )     (11,892 )
                                 
Net loss   $ (1,800,839 )   $ (561,392 )   $ (3,575,585 )   $ (1,606,949 )
                                 
Basic and diluted earnings per share on net loss   $ (0.18 )   $ (0.06 )   $ (0.36 )   $ (0.18 )
                                 
Weighted average shares outstanding - basic and diluted     10,058,259       10,058,259       10,058,259       8,852,439  

 

See accompanying notes to the consolidated financial statements.

 

3

 

 

Piezo Motion Corp. (f/n/a DTI Motion Corp.) and Subsidiary

Consolidated Statement of Changes in Stockholders’ Equity (Deficit)

Unaudited from January 1, 2021 through September 30, 2021

 

    Series A
Preferred Stock
    Series B
Preferred Stock
    Series C
Preferred Stock
    Common Stock     Additional
Paid in
    Accumulated        
    Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Capital     Deficit     Total  
Balance December 31, 2020     -     $ -       -     $ -       -     $ -       10,058,259     $ 1,006     $ 11,169,643     $ (13,178,237 )   $ (2,007,588 )
                                                                                         
Net loss     -       -       -       -       -       -       -       -       -       (654,004 )     (654,004 )
                                                                                         
Balance March 31, 2021     -       -       -       -       -       -       10,058,259       1,006       11,169,643       (13,832,241 )     (2,661,592 )
                                                                                         
Net loss     -       -       -       -       -       -       -       -       -       (1,120,742 )     (1,120,742 )
                                                                                         
Balance June 30, 2021     -       -       -       -       -       -       10,058,259       1,006       11,169,643       (14,952,983 )     (3,782,334 )
                                                                                         
Net loss     -       -       -       -       -       -       -       -       -       (1,800,839 )     (1,800,839 )
                                                                                         
Balance September 30, 2021     -     $ -       -     $ -       -     $ -       10,058,259     $ 1,006     $ 11,169,643     $ (16,753,822 )   $ (5,583,173 )

 

See accompanying notes to the consolidated financial statements.

 

4

 

 

Piezo Motion Corp. (f/n/a DTI Motion Corp.) and Subsidiary

Consolidated Statement of Changes in Stockholders’ Equity (Deficit)

Unaudited from January 1, 2020 through September 30, 2020

 

    Series A
Preferred Stock
    Series B
Preferred Stock
    Series C
Preferred Stock
    Common Stock     Additional
Paid in
    Accumulated        
    Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Capital     Deficit     Total  
Balance December 31, 2019     2,766,317     $ 277       2,424,265     $ 242       5,070,157     $ 507       7,678,535     $ 768     $ 10,407,450     $ (10,375,208 )   $ 34,036  
                                                                                         
Sale of Series C Preferred Stock     -       -       -       -       80,000       8       -       -       53,456       -       53,464  
                                                                                         
Warrants issued in connection with the sale of Series C Preferred Stock     -       -       -       -       -       -       -       -       46,536       -       46,536  
                                                                                         
Net loss     -       -       -       -       -       -       -       -       -       (352,049 )     (352,049 )
                                                                                         
Balance March 31, 2020     2,766,317     $ 277       2,424,265     $ 242       5,150,157     $ 515       7,678,535     $ 768     $ 10,507,442     $ (10,727,257 )   $ (218,013 )
                                                                                         
Issuance of common stock for director services     -       -       -       -       -       -       210,000       21       34,084       -       34,105  
                                                                                         
Recapitalization at reverse merger - May 20, 2020     (2,766,317 )     (277 )     (2,424,265 )     (242 )     (5,150,157 )     (515 )     2,111,465       211       618,673       -       617,850  
                                                                                         
Issuance of common stock for services     -       -       -       -       -       -       58,259       6       9,444       -       9,450  
                                                                                         
Net loss     -       -       -       -       -       -       -       -       -       (693,508 )     (693,508 )
                                                                                         
Balance June 30, 2020     -       -       -       -       -       -       10,058,259       1,006       11,169,643       (11,420,765 )     (250,116 )
                                                                                         
Net loss     -       -       -       -       -       -       -       -       -       (561,392 )     (561,392 )
                                                                                         
Balance September 30, 2020     -     $ -       -     $ -       -     $ -       10,058,259     $ 1,006     $ 11,169,643     $ (11,982,157 )   $ (811,508 )

 

See accompanying notes to the consolidated financial statements. 

 

5

 

 

Piezo Motion Corp. (f/n/a DTI Motion Corp.) and Subsidiary

Unaudited Consolidated Statements of Operations

 

    For the nine months ended  
    September 30,  
    2021     2020  
             
Cash Flows from Operating Activities            
Net loss   $ (3,575,585 )   $ (1,606,949 )
                 
Adjustments to reconcile net loss to net cash used by operating activities:                
Depreciation     19,736       13,014  
Gain on forgiveness of paycheck protection loan     (112,338 )     -  
Amortization of right of use asset     1,685       -  
Changes in operating assets and liabilities                
Accounts receivable     (2,529 )     -  
Due from related parties     (43,423 )     -  
Inventory     (62,239 )     (25,587 )
Advances to officers     1,060       (568 )
Deposits and prepaid expenses     (33,511 )     (187,750 )
Accounts payable and accrued liabilities     833,008       789,488  
Accrued interest     182,575       -  
Net cash used by operating activities     (2,791,561 )     (1,018,352 )
                 
Cash Flows from Investing Activities                
Issuance of notes receivable     (603,067 )     -  
Cash paid for property, plant and equipment     (38,339 )     (4,977 )
Net cash used by investing activities     (641,406 )     (4,977 )
                 
Cash Flows from Financing Activities                
Issuance of common stock     -       305,000  
Proceeds from notes payable     3,469,982       650,000  
Proceeds from paycheck protection loan     -       111,477  
Proceeds from issuance of Series C Preferred Stock     -       100,000  
Net cash provided by financing activities     3,469,982       1,166,477  
                 
Increase in cash and cash equivalents     37,015       144,222  
                 
Cash and cash equivalents at beginning of period     68,943       169,501  
                 
Cash and cash equivalents at end of period   $ 105,958     $ 313,723  
                 
Supplemental Cash Flow Information                
Cash paid for interest   $ -     $ -  
Cash paid for income taxes   $ -     $ -  

 

 See accompanying notes to the consolidated financial statements. 

 

6

 

 

PIEZO MOTION CORP. (F/N/A DTI MOTION CORP.) AND SUBSIDIARY

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

 

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

 

Piezo Motion Corp., formerly known as DTI Motion Corp. (“Motion” or “the Company”) was formed as a Delaware corporation on January 24, 2020. The initial shareholding was set up on March 15, 2020 and a share offering was made at the end of March, 2020. On March 27, 2020, Motion entered into a secured, short-term loan in an amount up to $249,000 to Discovery Technology International, Inc. (“DTI”) for the purpose of funding of operations. The loan maturity was April 27, 2020. DTI was unable to repay the loan and the shareholders authorized a merger between Motion (legal acquirer) and DTI (accounting acquirer) which was completed on May 20, 2020. See Note 3 for further details on the share exchange.

 

DTI’s office is located in Sarasota, Florida. DTI is a company focused on the ultrasonic standing wave-type piezo motor technology for rotary and linear motion. DTI has experience in the research and development, as well as the manufacturing, of piezo motors for high-tech industries across the globe.

 

The Company changed its name from DTI Motion Corp. to Piezo Motion Corp. on February 1, 2021.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The significant accounting policies of the Company are as follows:

 

Basis of Presentation and Consolidation

 

The Company has one wholly-owned subsidiary: Discovery Technology International, Inc. (“DTI”). The consolidated financial statements, which include the accounts of the Company and its wholly-owned subsidiary, are prepared in conformity with generally accepted accounting principles in the United States of America (U.S. GAAP). All significant intercompany balances and transactions have been eliminated. The consolidated financial statements, which include the accounts of the Company and its wholly-owned subsidiary, and related disclosures, have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Financial Statements have been prepared using the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and presented in US dollars. The year end is December 31.

 

Use of Estimates

 

Management uses estimates and assumptions in preparing financial statements. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could differ from these estimates and assumptions.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains deposits primarily in one financial institution, which may at times exceed amounts covered by insurance provided by the U.S. Federal Deposit Insurance Corporation (“FDIC”). The Company has not experienced any losses related to amounts in excess of FDIC limits.

 

Fair Value of Financial Instruments

 

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

 

7

 

 

The following are the hierarchical levels of inputs to measure fair value:

 

Level 1 – Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

 

Level 2 – Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

Level 3 – Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and interest, certain notes payable, approximate their fair values because of the short maturity of these instruments. The Company accounts for its equity instruments (such as warrants and stock-based compensation) at fair value.

 

Property, Plant and Equipment

 

Property, plant and equipment are carried at cost. Depreciation is provided on the straight-line method over the assets estimated service lives. Expenditures for maintenance and repairs are charged to expense in the period in which they are incurred, and betterments are capitalized. The cost of assets sold or abandoned and the related accumulated depreciation are eliminated from the accounts and any gains or losses are reflected in the accompanying statements of operations of the respective period. The estimated useful lives range from 3 to 7 years.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, “Revenue from contracts with customers,” (Topic 606). Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company’s main revenue stream is from product sales. The performance obligation associated with a typical product sale will be satisfied upon shipment to the customer, and the revenue will be recognized at that time.

 

The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, the Company’s performance obligations are transferred to customers at a point in time, typically upon delivery.

 

Inventory Valuation

 

Inventories including raw materials, work-in-process, and finished goods are valued at the average cost method.

 

8

 

 

Income Taxes

 

The Company follows Section 740-10-30 of the FASB ASC, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the fiscal year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the fiscal years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date. Through September 30, 2021, the Company has an accumulated deficit. Due to uncertainty of realization for these losses, a full valuation allowance is expected. Accordingly, no provision has been made for federal income taxes in the accompanying financial statements.

 

Net Income (Loss) Per Common Share

 

The Company computes loss per common share, in accordance with FASB ASC Topic 260, Earnings Per Share, which requires dual presentation of basic and diluted earnings per share. Basic income or loss per common share is computed by dividing net income or loss by the weighted average number of common shares outstanding during the period. Diluted income or loss per common share is computed by dividing net income or loss by the weighted average number of common shares outstanding, plus the issuance of common shares, if dilutive, that could result from the exercise of outstanding stock options and warrants. 

 

Stock based compensation

 

The Company records stock-based compensation in accordance with the provisions of FASB ASC Topic 718, “Accounting for Stock Compensation,” which establishes accounting standards for transactions in which an entity exchanges its equity instruments for goods or services. In accordance with guidance provided under ASC Topic 718, the Company recognizes an expense for the fair value of its stock awards at the time of grant and the fair value of its outstanding stock options as they vest, whether held by employees or others. As of September 30, 2021 and December 31, 2020 there were no options outstanding.

 

Recently Adopted Accounting Pronouncements

 

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

NOTE 3 – EXCHANGE AGREEMENT

 

On April 8, 2020, Piezo Motion Corp (“Motion”) along with Discovery Technology International, Inc., a Delaware corporation (“DTI”) and DTIM, Inc., a newly formed, wholly-owned subsidiary of DTIM (the “Merger- Sub”) entered into a merger agreement. The merger was considered effective on May 20, 2020. As part of the agreement the Merger-Sub merged with and into DTI with DTI surviving as a wholly-owned subsidiary of Motion and all outstanding shares of the Company’s common stock (“DTI Common Stock”), Series A Preferred Stock (“DTI Series A Preferred Stock”), Series B Preferred Stock (“DTI Series B Preferred Stock”) and Series C Preferred Stock (“DTI Series C Preferred Stock”) and together with the DTI Company Common Stock, collectively, the “DTI Capital Stock”), automatically converted into shares of common stock of DTIM (“DTIM Common Stock”). In addition, all outstanding DTI stock options (“DTI Stock Options”) granted under DTI’s equity incentive plan (the “DTI EIP”) and common stock purchase warrants (“DTI Warrants”) were cancelled. Holders of such cancelled DTI Warrants received shares of Motion Common Stock, all in consideration for and settlement of each holder’s cancellation of its DTI Warrants.

 

The merger has been accounted for as a reverse merger transaction, with DTI as the accounting acquirer and Motion as the accounting acquiree. The acquisition of a private operating company (“DTI”) by a nonoperating shell company (“Motion”) is considered in substance, a capital transaction rather than a business combination (or asset acquisition). That is, the transaction is a reverse recapitalization, equivalent to the issuance of shares by the private operating company for the net monetary assets of the shell company accompanied by a recapitalization. There is no goodwill or other intangible assets recognized.

 

9

 

 

NOTE 4 – PROPERTY, PLANT AND EQUIPMENT

 

Property, plant and equipment consisted of the following at September 30, 2021 and December 31, 2020:

 

    September 30,     December 31,  
    2021     2020  
             
Computer equipment   $ 16,221     $ 4,164  
Machinery and equipment     140,149       121,433  
Leasehold improvements     12,283       5,000  
Less: Accumulated depreciation     (58,308 )     (38,855 )
Total, net   $ 110,345     $ 91,742  

 

Depreciation expense was $19,736 and $13,014 for the nine months ended September 30, 2021 and 2020, respectively.

 

NOTE 5 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses as of September 30, 2021 and December 31, 2020, consisted of the following:

 

    September 30,     December 31,  
    2021     2020  
             
Accounts payable   $ 738,322     $ 398,155  
Accrued payroll     1,430,924       997,410  
Credit card payable     103,105       42,361  
Accrued director fees     5,133       5,133  
Accrued - other     -       1,417  
Total   $ 2,277,484     $ 1,444,476  

 

NOTE 6 – NOTES PAYABLE

 

In July 2020, Motion made an offering of convertible notes not to exceed approximately $2,400,000. In October and extended in April, June and August 2021, the Board authorized increasing the potential investment to not exceed $5,000,000. Unless earlier terminated by the Company, the offering shall terminate on September 30, 2021. These notes are payable by October 13, 2021, interest accruing at 10% per annum. At the completion of a qualifying investment, Motion, at its sole discretion may convert the loans and any accrued interest to common stock with a 120% multiplier on the value of the common stock in the qualifying investment. As of September 30, 2021 and December 31, 2020, the carrying amount of these notes was $4,119,982 and $650,000, respectively with accrued interest of $208,480 and $26,766, respectively.

 

NOTE 7 – PAYCHECK PROTECTION LOAN

 

In May 2020, DTI received a Paycheck Protection Program (PPP) loan under the terms of the CARES Act in the amount of $106,477 and an Economic Industry Disaster Loan (“EIDL”) of $5,000. The interest rate on the PPP loan is 1% fixed with a term of 24 months. DTI applied for and was granted loan forgiveness. As a result, DTI recorded a gain on forgiveness of PPP loan in the amount of $112,338.

 

NOTE 8 – EQUITY

 

On May 20, 2020 a merger was completed between Motion and DTI. The merger was approved by over 66% of all classes of stock for both Motion and DTI. Terms for the merger were included in a confidential term sheet. All common stock, preferred stock Series A, B and C, and warrants of DTI were converted. All DTI options were cancelled as of the merger date. See Footnote 3. The conversion ratio for the different classes of stock were agreed to by the shareholders in the merger. The conversion ratios were as follows:

 

    Conversion ratio  
DTI Pre-merger stockholders (Common Stock)     16.13  
DTI Pre-merger stockholders (Series A)     5.76  
DTI Pre-merger stockholders (Series B)     5.38  
DTI Pre-merger stockholders Series B Exchange Warrants     16.13  
DTI Pre-merger stockholders (Series C)     3.75  
DTI Pre-merger stockholder Series C Exchange Warrants     8.06  
Placement Agent Warrants     1.61  

 

10

 

 

Common stock

 

Prior to the merger, the Company issued 210,000 shares to directors for services, valued at $34,105.

 

On May 20, 2020, in connection with the merger, 2,111,465 shares of common stock were issued. After the merger and recapitalization on May 20, 2020, there were 10,000,000 shares issued and outstanding.

 

On June 10, 2020, 24,759 shares were issued for commission on the March 2020 investment in Motion. Inclusive of shares issued to preserve anti-dilution of 33,500, the total shares issued were 58,259. The shares were valued at $9,450.

 

As of September 30, 2021 and December 31, 2020, there were 10,058,259 shares issued and outstanding.

 

NOTE 9 – COMMITMENTS AND CONTINGENCIES

 

During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with FASB ASC 450-20-50, Contingencies. The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals. As of September 30, 2021, the Company is not aware of any contingent liabilities that should be reflected in the financial statements.

 

The Company entered into employment agreements with its President and Chief Executive Officer as of March 15, 2020. Under the terms of these agreements the Company will be liable for severance and other payments under certain conditions. The employment agreements are for a period of 36 months and may be terminated by the Chief Executive Officer or President upon three months written notice.

 

The Company entered into a facilities’ lease on January 1, 2020 for a premise located at 6968 Professional Parkway East, Sarasota, FL 34240. The lease period is for one year. Under Topic 842, a short-term lease is a lease that, at the commencement date, has a ‘lease term’ of 12 months or less and does not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise. Although short-term leases are in the scope of Topic 842, a simplified form of accounting is permitted. A lessee can elect, by class of underlying asset, not to apply the recognition requirements of Topic 842 and instead to recognize the lease payments as lease cost on a straight-line basis over the lease term. The Company has elected the short-term method to account for these leases.

 

NOTE 10 – GOING CONCERN

 

The Company’s financial statements are prepared using the generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. At September 30, 2021 and December 31, 2020, the Company had $105,958 and $68,943 in cash and $5,762,726 and $1,987,853 in negative working capital, respectively.  For the nine months ended September 30, 2021 and 2020, the Company had a net loss of $3,575,585 and $1,606,949, respectively. Continued losses may adversely affect the liquidity of the Company in the future. In view of the matters described in the preceding paragraph, recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheets is dependent upon continued operations of the Company, which in turn is dependent upon the Company’s ability to raise additional capital, obtain financing and to succeed in its future operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

11

 

 

NOTE 11 – OPERATING LEASE RIGHT-OF-USE ASSET AND OPERATING LEASE LIABILITY

 

The Company leases 3,562 square feet of office space located at The Cannon Building at 6710 Professional Parkway West, Sarasota, FL 34240. The Company entered into a third party lease agreement commencing on February 1, 2021 through February 1, 2024 with a base rent of $6,530 per month for year 1, $6,726 for year 2 and $6,928 for year 3.

 

Operating lease right-of-use assets and liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value is our incremental borrowing rate, estimated to be 10%, as the interest rate implicit in most of our leases is not readily determinable. Operating lease expense is recognized on a straight-line basis over the lease term. During the nine months ended September 30, 2021, the Company recorded $40,021 as operating lease expense which is included in general and administrative expenses on the statements of operations.

 

Right-of- use assets are summarized below:

 

    September 30,
2021
 
Office lease   $ 223,481  
Less: accumulated amortization     (44,111 )
Right-of-use assets, net   $ 179,370  

 

Operating lease liabilities are summarized below:

 

    September 30,
2021
 
Office lease   $ 181,055  
Less: current portion     (70,893 )
Long term portion   $ 110,162  
         
Maturity of lease liabilities are as follows:        
Year ending December 31, 2021   $ 20,864  
Year ending December 31, 2022     85,753  
Year ending December 31, 2023     88,325  
Year ending December 31, 2024     7,378  
      202,320  
Less: imputed interest     (21,265 )
Lease liability   $ 181,055  

 

NOTE 12 – RELATED PARTY TRANSACTIONS

 

The Company reimbursed $39,600 of rent paid by the CEO, Hassan Kotob, for an office rented by a company he controls. The rent is paid to a third-party rental agency. Piezo Motion is not a party to the lease; however, the space has been used extensively for Company business since April 2020.

 

On June 22, 2021, Motion loaned $70,000 to Brain Scientific, Inc. The note is at 0% interest and is due on September 30, 2021. On July 08, 2021, Motion loaned $130,000 to Brain Scientific, Inc.  The note is at 0% interest and is due on September 30, 2021. On August 09, 2021, Motion loaned $130,000 to Brain Scientific, Inc. The note is at 0% interest and is due on September 30, 2021. On September 01, 2021, Motion loaned $273,000 to Brain Scientific, Inc. The note is at 10% interest and is due on September 30, 2021. These loans are included in loans receivable – related party on the accompanying balance sheet as of September 30, 2021

 

The Company had advanced the president of the Company $6,482 as of September 30, 2021. This amount is included in advances to officers on the accompanying balance sheet.

 

The Company made payments on behalf of related parties amounting to $43,423 as of September 30, 2021. The balance is included in due from related parties on the accompanying balance sheet.

 

12

 

 

NOTE 13 – MERGER

 

On June 11, 2021, Motion entered into an Agreement and Plan of Merger and Reorganization among Brain Scientific, Inc., a Nevada corporation, BRSF Acquisition, Inc., a Delaware corporation, and Piezo Motion Corp., a Delaware corporation, dated June 11, 2021 (“the Agreement”). The merger has been closed on October 1, 2021. Per the Agreement, Motion shareholders will receive 50% of the fully-diluted shares of Brain Scientific, Inc.

 

NOTE 14 – SUBSEQUENT EVENTS

 

In accordance with ASC 855 “Subsequent Events,” Company management reviewed all material events through the date this report was issued, and the following subsequent events took place.

 

On June 11, 2021 Brain Scientific Inc. (the “Company”) entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Piezo Motion Corp., a Delaware corporation (“Piezo”), and BRSF Acquisition Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub was to be merged with and into Piezo, whereby Merger Sub would cease to exist and Piezo would survive as a wholly owned subsidiary of the Company (the “Merger”). On October 1,2021 the Company, Piezo and the Merger Sub entered into an Amendment to Merger Agreement (the “Merger Agreement Amendment”) to revise certain provisions within the Merger Agreement involving the post-Merger composition of Company management and certain post-Merger arrangements with the Company’s outgoing principal executive officer. The Merger was completed on October 1, 2021.

 

At the effective time of the Merger on October 1, 2021 (the “Effective Time”), shares of common stock, par value $0.0001 per share, of Piezo, representing all of Piezo’s issued and outstanding common stock immediately prior to the Effective Time (the “Piezo Shares”) were converted into an aggregate of 29,520,454 shares of common stock, par value $0.001 per share of the Company (the “Merger Shares”), with such Merger Shares representing, upon issuance, 50% of the Company’s issued and outstanding common stock on a fully diluted basis. At the Effective Time, Piezo had no outstanding options, warrants, convertible notes or other securities exercisable for or convertible into shares of Piezo common stock

 

On October 1, 2021 at the completion of the merger, convertible notes in the amount of $4,119,982 were exchanged for a private placement in Brain Scientific. The exchanged debt carries a 10% interest, matures on April 1, 2023 and has a 50% warrant coverage.

 

 

13

 

 

Exhibit 99.3

 

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

 

On June 11, 2021, Brain Scientific Inc. (the “Company”) entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Piezo Motion Corp., a Delaware corporation (“Piezo”), and BRSF Acquisition Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub was to be merged with and into Piezo, whereby Merger Sub would cease to exist and Piezo would survive as a wholly owned subsidiary of the Company (the “Merger”). On October 1, 2021 the Company, Piezo and the Merger Sub entered into an Amendment to Merger Agreement (the “Merger Agreement Amendment”) to revise certain provisions within the Merger Agreement involving the post-Merger composition of Company management and certain post-Merger arrangements with the Company’s outgoing principal executive officer, Boris Goldstein. The Merger was completed on October 1, 2021.

 

At the effective time of the Merger (the “Effective Time”), all of Piezo’s issued and outstanding common stock immediately prior to the Effective Time (the “Piezo Shares”) were converted into an aggregate of 29,520,454 shares of common stock, par value $0.001 per share of the Company (the “Merger Shares”), with such Merger Shares representing, upon issuance, 50% of the Company’s issued and outstanding common stock on a fully diluted basis. At the Effective Time, Piezo had no outstanding options, warrants, convertible notes or other securities exercisable for or convertible into shares of Piezo common stock

 

At the Effective Time, the board of directors of the Company (the “Board”) was increased from two directors to five directors. Boris Goldstein resigned as the chairman and as a director of the Company and Hassan Kotob was appointed to fill one of the board vacancies created thereby. Nickolay Kukekov remained as a director following the Effective Time. As of October 1, there were three existing vacancies to the Board. On November 15, 2021, three independent directors were appointed to the Board. At the Effective Time, Boris Goldstein also resigned as the Company’s principal executive officer and from all other executive officer positions then held by him, Mark Corrao resigned as the Company’s chief financial officer, Hassan Kotob was appointed as the Company’s chief executive officer, and Bonnie-Jeanne Gerety was appointed as the Company’s chief financial officer.

 

In conjunction with the closing of the Merger, on October 1, 2021 the Company entered into an executive employment agreement with Hassan Kotob (the “Kotob Employment Agreement”), pursuant to which Mr. Kotob is serving as the Company’s Chief Executive Officer and as the Chairman of our Board of Directors. Pursuant thereto, Mr. Kotob is receiving a base annual salary of $390,000. Mr. Kotob is also eligible to receive annual performance bonuses of not less than $250,000 upon the Company achieving certain agreed to milestones. Upon a termination of the Kotob Employment Agreement by Mr. Kotob for good reason or by the Company without cause, Mr. Kotob is entitled to continue to receive his then current base salary until a date that is the later of (A) the 3 year anniversary of the commencement date of the Kotob Employment Agreement, or (B) the 12 month anniversary of the effective date of such termination and is also eligible to receive a severance bonus in an amount equal to a pro-rata portion of the annual bonus to which Mr. Kotob may have been entitled for the year in which termination takes place. The Kotob Employment Agreement will continue until terminated by either party.

 

In conjunction with the closing of the Merger, and as a condition to the Merger, the Company transferred all of the Company’s pre-Merger operating assets and liabilities to the Company’s wholly-owned subsidiary, MemoryMD, Inc., such that immediately following the closing of the Merger, the Company became a holding company. The terms and conditions of the transfer are set forth in the Assignment and Assumption Agreement dated September 10, 2021 between the Company and MemoryMD, Inc. (the “Assignment and Assumption Agreement”).

 

Effective September 28, 2021 and September 30, 2021, respectively, Boris Goldstein and Vadim Sakharov entered into Assignment Agreements (the “Goldstein Assignment Agreement” and the “Sakharov Assignment Agreement”) under which they each confirmed their previous assignment of the full and exclusive right, title and interest in and to all Proprietary Information (as such term is defined in the Assignment Agreements) and Inventions (as such term is defined in the Assignment Agreements) related to their employment by the Company and Memory MD, Inc. to Memory MD, Inc. and its successors and assigns.

 

 

 

 

Pursuant to the Merger Agreement Amendment, as amended, the Company agreed to make the following payments to Boris Goldstein:

 

(i) 149,000 of accrued payroll payment upon the Company raising an aggregate $5,000,000 in capital after the closing;

 

(ii) $200,000 upon the Company raising an aggregate of $10,000,000 in capital after the closing (inclusive of proceeds raised the Offering) and such cash payment shall be held in escrow for 12 months against any liabilities arising prior to the Merger closing;

 

(iii) $150,000 upon the Company listing its securities on a senior exchange such as NASDAQ or the New York Stock Exchange; and

 

(iv) $250,000 upon completion of performance metrics as specified by Hassan Kotob, in his capacity as the Company’s chief executive officer.

 

The payment referenced in (i) above was made at the closing of the Merger.

 

The completion of the Merger was subject to various customary conditions, including, among other things: (a) the approval of the respective stockholders and boards of directors of the Company, Merger Sub, and Piezo; (b) subject to certain materiality exceptions, the accuracy of the representations and warranties made by each of the Company and Piezo and the compliance by each of the Company and Piezo with their respective obligations under the Merger Agreement; (c) approval of the transactions contemplated by the Merger Agreement by any third-parties and governmental entities as required by law; (d) the execution and delivery of an assignment and assumption agreement between the Company and MemoryMD, a wholly-owned subsidiary of the Company, pursuant to which the Company assigned to MemoryMD, and MemoryMD assumed from the Company, all of the Company’s per-Merger operating assets and liabilities, subject to certain exceptions; (e) the completion of all necessary legal due diligence by each of the Company and Piezo; (f) the first closing of a capital raise by the Company of at least $5.0 million (the “Offering”), including any interim bridge financing raised by either Company or Piezo that was convertible into the Offering, consisting of a 10% convertible promissory note and common stock purchase warrants, upon the terms and subject to the conditions of a separate securities purchase agreement; and (g) the number of shares of Piezo common stock held by Piezo stockholders who did not vote to adopt the Merger Agreement could not exceed 10% of the number of outstanding shares of Piezo common stock as of the Effective Time. 92.44% of the Piezo stockholders voted to adopt the Merger Agreement and no Piezo stockholders asserted appraisal rights. Holders of the Company’s Common Stock did not have appraisal rights in connection with the Merger or any of the other actions described in this Report.

 

Closing Under Note Offering and Debt Conversions

 

In conjunction with the closing of the Merger, the Company conducted an initial closing under a private offering (the “Offering”) of 10% convertible promissory notes due and payable on April 1, 2023 (the “Notes”). At the initial closing, an aggregate of $2,850,000, net of original debt discount of $100,000, in Notes was closed on. At that same time, (i) an aggregate of $4,328,462 of debt of Piezo and an aggregate of $1,483,905 of debt of the Company was converted into Notes. Each holder of a Note, provided that the Note is still then outstanding, will be issued on the earlier of (i) the date, if any, upon which the Company’s common stock is listed for trading on the NASDAQ stock exchange (the “Uplist”), and (ii) the date that is eighteen months from the date of issuance, a warrant (the “Warrant”) to purchase an amount of shares of Company common stock, equal to such holder’s Warrant Share Amount. For purposes of the foregoing, a holder’s “Warrant Share Amount” means (i) if such Warrant is issued in connection with the Uplist, one half of the initial principal balance of such holder’s Note at issuance divided by the lesser of (A) $0.90, and (B) and the greater of (x) $0.20 and (y) one hundred twenty percent (120%) of the closing price for the Company’s common stock on the trading day prior to the date of the Uplist, and (ii) if such Warrant is issued otherwise than in connection with the Uplist, the initial principal balance of such holder’s Note, divided by the lesser of (A) $0.90, and (B) and the greater of (x) $0.20 and (y) one hundred twenty percent (120%) of the volume weighted average price (“VWAP”) for the Company’s common stock over the five consecutive trading days immediately preceding the date that is eighteen months from the date of issuance.

 

2

 

 

The Notes contain mandatory and voluntary conversion features as follows:

 

(a) Mandatory Conversion.

 

(i) The Notes automatically convert into shares of the Company’s common stock or Units, as provided below, immediately upon the earliest to occur of (a) the Uplist, and (b) a Subsequent Qualified Financing Date. For purposes of the Notes, a “Unit” means the combination of common stock and warrants to purchase common stock offered by the Company in any financing occurring simultaneously with the Uplist (“Simultaneous Uplist Unit Offering”). For purposes of a Note, “Subsequent Qualified Financing Date” means the date on which the Company has received proceeds in excess of $5,000,000 from a transaction or series of related transactions occurring prior to the maturity date of the Note, including, but not limited to, equity financings, business combinations or other issuances of the Company’s equity securities (not including the transactions contemplated by the Purchase Agreement for the Offering).

 

(ii) If a Note is being converted in connection with an Uplist, and no Simultaneous Uplist Unit Offering has occurred, the Note will be convertible into a number of shares of Company common stock equal to the quotient of (I) the outstanding aggregate principal amount of the Note plus accrued but unpaid interest thereon, divided by (II) the lesser of (a) $0.90 and (b) the greater of (x) $0.20 and (y) eighty percent (80%) of closing price for the Company’s common stock on the trading day prior to the date of the Uplist.

 

(iii) If a Note is being converted in connection with an Uplist, and a Simultaneous Uplist Unit Offering has occurred, the Note will be convertible into a number of Units equal to the quotient of (I) the outstanding aggregate principal amount of the Note plus accrued but unpaid interest thereon, divided by (II) the lesser of (a) $0.90 and (b) the greater of (x) $0.20 and (y) eighty percent (80%) of the per Unit price in the Simultaneous Uplist Unit Offering.

 

(iv) If a Note is being converted upon a Subsequent Qualified Financing Date, the Note will be convertible into a number of shares of Company common stock equal to the quotient of (I) the outstanding aggregate principal amount of the Note plus accrued but unpaid interest thereon, divided by (II) the lesser of (a) $0.90 and (b) the greater of (x) $0.20 and (y) eighty percent (80%) of the VWAP for the common stock for the five consecutive trading days immediately preceding such Subsequent Qualified Financing Date.

 

(b) Voluntary Conversion.

 

(i) The Holder of a Note has the right (subject to the conversion limitations set forth therein) from time following the date of issuance to convert all or any part of the outstanding and unpaid principal and interest then due under the Note into fully paid and non-assessable shares of the Company’s common stock, as such common Stock exists on the date of issuance, or any shares of capital stock or other securities of the Company into which such common stock may thereafter be changed or reclassified at the Voluntary Conversion Price (as defined below).

 

(ii) If a Note is being converted pursuant to this Section 3(b), this Note shall be convertible into a number of shares of Common Stock equal to the quotient of (I) the outstanding aggregate principal amount of the Note plus accrued but unpaid interest thereon, divided by (II) the lesser of (a) $0.90 and (b) the greater of (x) $0.20 and (y) eighty percent (80%) of the VWAP for the Common Stock for the five (5) consecutive Trading Days immediately preceding the applicable conversion date (the “Voluntary Conversion Price”).

 

Option/Warrant Issuances

 

In connection with the Merger closing, the Company issued an aggregate of 10,009,365 options and warrants (5,505,151 warrants and 4,504,214 options) to six persons, such aggregate amount equaling, in the aggregate, 20% of the issued and outstanding shares of Company’s common stock immediately after the Merger closing. The recipients included Nickolay Kukekov (2,001,873 options), Boris Goldstein (2,001,873 warrants) and Hassan Kotob (2,502,341 options.). Each option and warrant has a ten year term, is fully exercisable upon issuance and has an exercise price of $0.35 which was the closing price for the Company’s common stock on October 1, 2021.

 

3

 

 

The unaudited pro forma condensed combined balance sheet as of September 30, 2021 gives pro forma effect to the Merger as if it had been consummated as of that date. The unaudited pro forma condensed combined statements of operation for the nine months ended September 30, 2021 and twelve months ended December 31, 2020 give pro forma effect to the Business Combination as if it had occurred as of January 1, 2020, the beginning of the earliest period presented:

 

The unaudited pro forma condensed combined balance sheet as of September 30, 2021 has been prepared using the following:

 

The Company unaudited historical balance sheet as of September 30, 2021, as incorporated in this Current Report on Form 8-K/A and
     
Piezo’s unaudited historical balance sheet as of September 30, 2021, as incorporated in this Current Report on Form 8-K/A.

 

The unaudited pro forma condensed combined statements of operation for the nine months ended September 30, 2021 and year ended December 31, 2020 have been prepared using the following:

 

The Company unaudited historical statement of operations for the nine months ended September 30, 2021, as incorporated in this Current Report on Form 8-K/A; and
     
Piezo’s unaudited historical statement of operations for the nine months ended September 30, 2021, as incorporated in this Current Report on Form 8-K/A.
     
The Company audited historical statement of operations for the year ended December 31, 2020, as incorporated in this Current Report on Form 8-K/A; and
     
Piezo’s audited historical statement of operations for the year ended December 31, 2020, as incorporated in this Current Report on Form 8-K/A.

 

The unaudited pro forma condensed consolidated financial information has been presented for informational purposes only and is not necessarily indicative of what the combined company’s financial position or results of operations actually would have been had the merger been completed as of the dates indicated. In addition, the unaudited pro forma condensed consolidated financial information does not purport to project the future financial position or operating results of the combined company. The historical consolidated financial information has been adjusted in the accompanying unaudited pro forma condensed consolidated financial information to give effect to unaudited pro forma events that are directly attributable to the merger, factually supportable and, with respect to the unaudited pro forma condensed consolidated statement of operations, expected to have a continuing impact on the results of operations of the combined company. The accompanying unaudited pro forma condensed consolidated statement of operations does not include any pro forma adjustments to reflect certain expected financial benefits of the merger, such as tax savings, cost synergies or revenue synergies, or the anticipated costs to achieve those benefits, including the cost of integration activities, or restructuring actions which may be achievable or the impact of any non-recurring activity and one-time transaction related costs.

 

4

 

 

Brain Scientific, Inc.

Pro Forma Condensed Combined Balance Sheet

September 30, 2021

(Unaudited)

 

    Historical     Pro Forma  
    Brain Scientific, Inc.     Piezo Motion Corporation and Subsidiary     Transaction Accounting Adjustments     Notes   Pro Forma Combined  
ASSETS                            
                             
CURRENT ASSETS:                                    
Cash   $ 26,519     $ 105,958     $ 2,850,000     (a)   $ 2,064,992  
                      (644,418 )   (f)        
                      (273,067 )   (m)        
Accounts receivable     15,352       2,529       -           17,881  
Due from related parties     -       43,423       -           43,423  
Inventory     1,814       107,143       -           108,957  
Advances to officers     -       6,482       -           6,482  
Prepaid expense and other current assets     57,838       45,511       (2,244 )   (h)     101,105  
Notes receivable - related party     -       603,067       (603,067 )   (h)     -  
Prepaid expenses and other current assets - related party     700       -       -           700  
Operating lease right-of-use asset     40,093       -       -           40,093  
TOTAL CURRENT ASSETS     142,316       914,113       1,327,204           2,383,633  
                                     
Property and equipment, net     -       110,345       -           110,345  
Right of use asset     -       179,370       -           179,370  
Intangible assets, Net     -       -       11,142,000     (c)     11,142,000  
Goodwill     -       -       6,607,173     (c)     6,607,173  
                                     
TOTAL ASSETS   $ 142,316     $ 1,203,828     $ 19,076,377         $ 20,422,521  
                                     
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)                                    
                                     
CURRENT LIABILITIES:                                    
Accounts payable and accrued expenses   $ 1,524,122     $ 2,277,484     $ (136,905 )   (g)   $ 3,662,457  
                      (2,244 )   (h)        
Accrued interest     -       208,480       (208,480 )   (g)     -  
Accounts payable and accrued expenses - related party     75,000       -       -           75,000  
Notes payable - current     1,149,916       4,119,982       (4,369,982 )   (g)     296,849  
                      (603,067 )   (h)        
Convertible notes payable, net, current portion     1,771,133       -       (880,000 )   (g)     618,066  
                      (273,067 )   (m)        
Derivative liabilities     1,745,483       -       (94,184 )   (m)     1,651,299  
Finance lease - short term     4,595       -       -           4,595  
Loans payable     6,667       -       -           6,667  
Loans payable - related party     373,003       -       (217,000 )   (g)     156,003  
Operating lease liability, current portion     42,375       70,893       -           113,268  
TOTAL CURRENT LIABILITIES     6,692,294       6,676,839       (6,784,929 )         6,584,204  
                                     
Convertible notes payable, net, net of current portion     -       -       2,850,000     (a)     6,471,775  
                      5,812,367     (g)        
                      (2,190,592 )   (i)        
Operating lease liability, net of current portion     -       110,162       -           110,162  
                                     
TOTAL LIABILITIES     6,692,294       6,787,001       (313,154 )         13,166,141  
                                     
STOCKHOLDERS’ EQUITY (DEFICIT)                                    
                                     
Preferred stock     -       -       -           -  
Common stock     20,526       1,006       (1,006 )   (b)     50,046  
                      29,520     (d)        
Additional paid in capital     3,924,999       11,169,643       (11,169,643 )   (b)     21,750,359  
                      12,136,480     (d)        
                      3,498,288     (e)        
                      2,190,592     (i)        
Accumulated deficit     (10,491,678 )     (16,753,822 )     16,753,822     (b)     (14,540,200 )
                      (644,418 )   (f)        
                      (3,498,288 )   (e)        
                      94,184     (m)        
Accumulated other comprehensive loss     (3,825 )     -       -           (3,825 )
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)     (6,549,978 )     (5,583,173 )     19,389,531           7,256,380  
                                     
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)   $ 142,316     $ 1,203,828     $ 19,076,377         $ 20,422,521  

 

See accompanying Notes to Unaudited Pro Forma Condensed Combined Financial Information

 

5

 

 

Brain Scientific, Inc.

Pro Forma Condensed Combined Consolidated Statements of Operations and Comprehensive Loss

September 30, 2021

(Unaudited)

 

    Historical     Pro Forma  
    Brain
Scientific,
Inc.
    Piezo Motion
Corporation and
Subsidiary
    Transaction
Accounting
Adjustments
    Notes   Pro Forma
Combined
 
                             
REVENUE   $ 526,797     $ 14,482     $ -         $ 541,279  
                                     
COST OF GOODS SOLD     335,801       7,840       -           343,641  
                                     
GROSS PROFIT     190,996       6,642       -           197,638  
                                     
SELLING, GENERAL, AND ADMINISTRATIVE                                    
Research and development     386,646       59,387       -           446,033  
Professional fees     508,802       -       -           508,802  
Sales and marketing     182,480       488,704       -           671,184  
Occupancy     -       -       -           -  
General and administrative     1,078,948       1,489,984       -           2,568,932  
Amortization and Depreciation expense             19,736       578,837     (n)     598,573  
Personnel expenses     -       1,454,180       -           1,454,180  
TOTAL SELLING, GENERAL AND ADMINISTRATIVE     2,156,876       3,511,991       578,837           6,247,704  
                                     
LOSS FROM OPERATIONS     (1,965,880 )     (3,505,349 )     (578,837 )         (6,050,066 )
                                     
OTHER INCOME (EXPENSE):                                    
Interest expense     (721,576 )     (182,574 )     (707,178 )   (j)     (2,756,624 )
                      (50,000 )   (k)        
                      (1,095,296 )   (l)        
Other income     (53 )     -       -           (53 )
Loss on debt extinguishment     (442,226 )     -       -           (442,226 )
Change in fair value of derivative liabilities     595,956       -       94,184     (m)     690,140  
Gain on forgiveness of paycheck protection loan     -       112,338       -           112,338  
Foreign currency transaction loss     (409 )     -       -           (409 )
TOTAL OTHER INCOME (EXPENSE)     (568,308 )     (70,236 )     (1,758,290 )         (2,396,834 )
                                     
LOSS BEFORE INCOME TAXES     (2,534,188 )     (3,575,585 )     (2,337,127 )         (8,446,900 )
                                     
PROVISION FOR INCOME TAXES     (628 )     -       -           (628 )
                                     
NET LOSS     (2,534,816 )     (3,575,585 )     (2,337,127 )         (8,447,528 )
                                     
OTHER COMPREHENSIVE INCOME (LOSS)                                    
Foreign currency translation adjustment     255       -       -           255  
TOTAL COMPREHENSIVE LOSS   $ (2,534,561 )   $ (3,575,585 )   $ (2,337,127 )       $ (8,447,273 )
                                     
NET LOSS PER COMMON SHARE                                    
Basic   $ (0.13 )   $ (0.36 )               $ (0.17 )
Diluted   $ (0.16 )   $ (0.36 )               $ (0.18 )
                                     
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING                                    
Basic     20,046,331       10,058,259       29,520,454     (d)     49,566,785  
Diluted     20,181,766       10,058,259       29,520,454     (d)     49,702,220  

 

See accompanying Notes to Unaudited Pro Forma Condensed Combined Financial Information

 

6

 

 

Brain Scientific, Inc.

Pro Forma Condensed Combined Consolidated Statements of Operations and Comprehensive Loss
December 31, 2020

(Unaudited)

 

    Historical     Pro Forma  
    Brain
Scientific,
Inc.
    Piezo Motion
Corporation and
Subsidiary
    Transaction
Accounting
Adjustments
    Notes   Pro Forma
Combined
 
                             
REVENUE   $ 544,275     $ 93,664     $ -         $ 637,939  
                                     
COST OF GOODS SOLD     409,302       43,762       -           453,064  
                                     
GROSS PROFIT     134,973       49,902       -           184,875  
                                     
SELLING, GENERAL, AND ADMINISTRATIVE                                    
Research and development     275,926       210,706       -           486,632  
Professional fees     478,461       -       -           478,461  
Sales and marketing     244,774       -       -           244,774  
Occupancy     38,870       -       -           38,870  
General and administrative     930,138       1,581,425       -           2,511,563  
Amortization and depreciation expense     -       -       771,782      (n)     771,782  
Personnel expenses     -       1,027,259       -           1,027,259  
TOTAL SELLING, GENERAL AND ADMINISTRATIVE     1,968,169       2,819,390       771,782           5,559,341  
                                     
LOSS FROM OPERATIONS     (1,833,196 )     (2,769,488 )     (771,782 )         (5,374,466 )
                                     
OTHER INCOME (EXPENSE):                                    
Interest expense     (3,526,325 )     (29,474 )     (942,903 )    (j)     (6,025,764 )
                      (66,667 )    (k)        
                      (1,460,395 )    (l)        
Other income     8,260       -       -           8,260  
Loss on disposal of assets     -       (4,067 )     -           (4,067 )
Loss on debt extinguishment     (294,301 )     -       -           (294,301 )
Change in fair value of derivative liabilities     1,360,754       -       94,184      (m)     1,454,938  
Gain on forgiveness of paycheck protection loan     -       -       -           -  
Foreign currency transaction loss     23       -       -           23  
TOTAL OTHER INCOME (EXPENSE)     (2,451,589 )     (33,541 )     (2,375,781 )         (4,860,911 )
                                     
LOSS BEFORE INCOME TAXES     (4,284,785 )     (2,803,029 )     (3,147,563 )         (10,235,377 )
                                     
PROVISION FOR INCOME TAXES     -       -       -           -  
                                     
NET LOSS     (4,284,785 )     (2,803,029 )     (3,147,563 )         (10,235,377 )
                                     
OTHER COMPREHENSIVE INCOME (LOSS)                                    
Foreign currency translation adjustment     (4,446 )     -       -           (4,446 )
TOTAL COMPREHENSIVE LOSS   $ (4,289,231 )   $ (2,803,029 )   $ (3,147,563 )       $ (10,239,823 )
                                     
NET LOSS PER COMMON SHARE                                    
Basic and diluted   $ (0.22 )   $ (0.31 )               $ (0.21 )
                                     
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING                                    
Basic and diluted     19,439,141       -       29,520,454     (d)     48,959,595  

 

See accompanying Notes to Unaudited Pro Forma Condensed Combined Financial Information

 

7

 

 

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

 

Note 1 - Description of Transaction

 

On June 11, 2021, Brain Scientific Inc. (the “Company”) entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Piezo Motion Corp., a Delaware corporation (“Piezo”), and BRSF Acquisition Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Merger Sub”). Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will be merged with and into Piezo, Merger Sub will cease to exist and Piezo will survive as a wholly-owned subsidiary of the Company (the “Merger”). On October 1,2021 the Company, Piezo and the Merger Sub entered into an Amendment to Merger Agreement (the “Merger Agreement Amendment”) to revise certain provisions within the Merger Agreement involving the post-Merger composition of Company management and certain post-Merger arrangements with the Company’s outgoing principal executive officer, Boris Goldstein. The Merger was completed on October 1, 2021.

 

At the effective time of the Merger (the “Effective Time”), each outstanding share of Piezo capital stock will be automatically converted into the right to receive that number of shares of Company common stock equal to 100% of the issued and outstanding shares of Company common stock on a “fully diluted basis” (as defined in the Merger Agreement) calculated as of the Effective Time (the “Exchange Ratio”). No fractional shares of Company common stock will be issued in the Merger. Following the consummation of the Merger, former stockholders of Piezo are expected to own approximately 50% of the Company and current stockholders of the Company are expected to own approximately 50% of the Company, in each case based on the fully diluted shares of the Company prior to the consummation of the Merger. The Exchange Ratio and the actual number of shares of Company common stock to be issued to the Piezo stockholders is not yet determinable and will be based on, in part, whether and to what extent the Company’s existing indebtedness is converted into Company common stock or repaid in cash at or prior to the Effective Time, and is expected to result in the former Piezo stockholders owning a majority of the Company’s issued and outstanding shares of common stock as of immediately after the Effective Time.

 

The Merger Agreement provides that, at or prior to the Effective Time, the board of directors of the Company (the “Board”) will take the following action, to be effective upon the Effective Time: (i) increase the size of the Company’s Board of Directors from 2 to 5 members, (ii) elect to the Board Hassan Kotob; and (iii) appoint as the officers of the Company Hassan Kotob and Bonnie-Jeanne Gerety, or, in either case with regard to clauses (ii) and (iii), such other persons designated by Piezo. The Merger Agreement also provides that the current officers of the Company shall resign from their positions with the Company effective upon the Effective Time; provided, however, that Boris Goldstein, currently the Company’s Chairman, Executive Vice President and Secretary, shall be appointed to serve for a period of one year as Chief Science Officer of the Company (or of MemoryMD, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“MemoryMD”)), effective upon the Effective Time, upon terms as set forth in the Merger Agreement In addition, Dr. Goldstein shall receive a special bonus as a result of the closing of the Merger and, further, is eligible to receive a special bonus in the event the Company uplists to a senior stock exchange. The members of the Company’s current Board shall continue to serve as directors of the Company following the Effective Time.

 

Note 2 - Basis of Pro Forma Presentation

 

The unaudited pro forma condensed combined balance sheet gives effect to the Merger as if it occurred on September 30, 2021. The unaudited pro forma condensed combined statements of operations and comprehensive loss for the nine months ended September 30, 2021 gives effect to the Merger as if it had occurred on January 1, 2021. The unaudited pro forma condensed combined statements of operations and comprehensive loss for the year ended December 31, 2020 gives effect to the Merger as if it had occurred on January 1, 2020.

 

Note 3 – Transaction Accounting Adjustments

 

a) Represents the closing of the private placement offering of $2,850,000, net of debt discount of $100,000, simultaneously with the closing and as a condition of the Merger.
   
b) Represents the elimination of Piezo Motion Corporation and Subsidiary common stock, additional paid in capital, and accumulated deficit.

 

8

 

 

c) Represents the estimate of goodwill resulting from the preliminary purchase price of $12,166,000, the acquisition of intangibles of $11,142,000, and the net assets and liabilities of Piezo Motion Corporation and Subsidiary assumed as of September 30, 2021. The estimate of goodwill is subject to materially change.
     
d) Represents the issuance of Brain Scientific, Inc. common shares upon consummation of the Merger
     
e) Represents the aggregate of 10,009,365 options and warrants (5,505,151 warrants and 4,504,214 options) to six persons, such aggregate amount equaling, in the aggregate, 20% of the issued and outstanding shares of Company’s common stock immediately after the Merger closing. Each option and warrant has a ten year term, is fully exercisable upon issuance and has an exercise price of $0.35 which was the closing price for the Company’s common stock on October 1, 2021.
     
f) Represents payments to $644,418 of various expenses paid in conjunction with the Merger.
     
g) Represents the aggregate of $4,328,462 of debt of Piezo and an aggregate of $1,483,905 of debt of the Company was converted into 10% convertible promissory notes due and payable on April 1, 2023.
     
h) Represents the elimination of an intercompany note and accrued interest owed from the Company to Piezo.
     
i) Represents the debt discount associated with the beneficial conversion feature on the convertible notes as the fair value of the Company’s common stock is greater than the effective conversion price on the date of issuance.
     
j) Represents the immediate vesting of the 10,009,365 options and warrants resulting in $3,498,288 of stock-based compensation expense for both the nine months ended September 30, 2021 and the year ended December 31, 2020.
     
k) Represents interest expense on the $8,762,367 convertible notes payable issued with the closing for a total of $707,178 and $942,903 for the nine months ended September 30, 2021 and the year ended December 31, 2020, respectively. Additionally, represents the reversal of interest expense on the notes that were converted to the convertible notes issued of $319,479 and $39,625 for the nine months ended September 30, 2021 and the year ended December 31, 2020, respectively.
     
l) Represents the amortization of the original issue discount for a total of $50,000 and $66,667 for the nine months ended September 30, 2021 and the year ended December 31, 2020, respectively.
     
m) Represents the amortization of the beneficial conversion feature for a total of $1,095,296 and $1,460,395 for the nine months ended September 30, 2021 and the year ended December 31, 2020, respectively.
     
n) Represents convertible notes payable paid off at the effective date, and the related write off the derivative liability.
     
  o) Represents the amortization of acquired intangibles for a total of $578,837 and $771,782 for the nine months ended September 30, 2021 and the year ended December 31, 2020, respectively.

 

 

9